These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19140232)

  • 41. [Clinical features of antiviral therapy-induced thyroid disease in patients with chronic hepatitis C].
    Liu JP; Hou HR; Kang Y; Shang J; Cao YG; Liang SQ; Jin X
    Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):257-60. PubMed ID: 24021785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C.
    Hsieh MC; Yu ML; Chuang WL; Shin SJ; Dai CY; Chen SC; Lin ZY; Hsieh MY; Liu JF; Wang LY; Chang WY
    Eur J Endocrinol; 2000 May; 142(5):431-7. PubMed ID: 10802518
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis.
    Nair Kesavachandran C; Haamann F; Nienhaus A
    PLoS One; 2013; 8(2):e55364. PubMed ID: 23383326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
    Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
    Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid Dysfunction in Chronic Hepatitis C Patients Treated with the Combined Pegylated Interferon-Ribavirin Therapy.
    Hamza I; Eid Y; El-Sayed M; Marzaban R; Abdul-Kareem S
    J Interferon Cytokine Res; 2016 Sep; 36(9):527-33. PubMed ID: 27333271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
    Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
    Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dysthyroidism and interferon-alpha: the withdrawal of interferon should not be systematic].
    Chédin P; Cahen-Varsaux J; Demmane S
    Gastroenterol Clin Biol; 1995 Apr; 19(4):442-4. PubMed ID: 7672530
    [No Abstract]   [Full Text] [Related]  

  • 48. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
    Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
    Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid dysfunction in a UK hepatitis C population treated with interferon-alpha and ribavirin combination therapy.
    Costelloe SJ; Wassef N; Schulz J; Vaghijiani T; Morris C; Whiting S; Thomas M; Dusheiko G; Jacobs M; Vanderpump MP
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):249-56. PubMed ID: 20148905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).
    Hass HG; Klein R; Nehls O; Kaiser S
    J Clin Gastroenterol; 2009; 43(5):470-6. PubMed ID: 19247202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy].
    Teng ZL; Gong WJ; Zhang SQ; Sun YX; Ma XH
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):101-4. PubMed ID: 23663880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
    Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
    Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Autoimmune diseases and treatment with interferon-alpha: review of the literature apropos of a case of hyperthyroidism].
    Dupont J; Orgiazzi J; Burger A
    Rev Med Interne; 1993 Feb; 14(2):93-9. PubMed ID: 8378632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practical management of patients treated with alpha interferon.
    Brenard R
    Acta Gastroenterol Belg; 1997; 60(3):211-3. PubMed ID: 9396177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C.
    Pittau E; Bogliolo A; Tinti A; Mela Q; Ibba G; Salis G; Perpignano G
    Clin Exp Rheumatol; 1997; 15(4):415-9. PubMed ID: 9272304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C.
    Pavan MH; Pavin EJ; Gonçales FL; Zantut-Wittmann DE; Wittmann DE
    Braz J Infect Dis; 2011; 15(5):449-56. PubMed ID: 22230851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
    Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
    Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
    Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ
    Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
    [No Abstract]   [Full Text] [Related]  

  • 59. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.
    Loftis JM; Wall JM; Linardatos E; Benvenga S; Hauser P
    J Endocrinol Invest; 2004; 27(7):RC16-20. PubMed ID: 15505982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.